Skip to main content

The Pathophysiology of Hypertension: Contributions of Experimental Pathophysiology

  • Chapter
Hypertensive Cardiovascular Disease: Pathophysiology and Treatment

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 16))

  • 232 Accesses

Abstract

The description of the pathogenic events which underly the production of any particular disease is a relatively easy exercise when the etiology of the disease and its symptoms are well established. However, such is not the case with hypertension, for high blood pressure is not itself a disease but merely one of a family of common symptomatic manifestations which develop in response to various pathologies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Report of the Hypertension Task Force. National Institutes of Health; Heart, Blood and Lung Institute. Volume 1: General Summary and Recommendations, p. 1628. NIH Publication No. 79, 1979.

    Google Scholar 

  2. Guyton AC, Coleman TG, Cowley AW Jr, Manning RD Jr, Norman RA Jr, Ferguson JD: A systems analysis approach to understanding long-range arterial blood pressure control and hypertension. Circ Res 35: 159, 1974.

    Google Scholar 

  3. Cowley A: Personal communication.

    Google Scholar 

  4. McCubbin JW, Green JH, Page IH: Baroreceptor function in chronic renal hypertension. Circ Res 4: 205, 1956.

    PubMed  CAS  Google Scholar 

  5. Kezdi P, Wennemark J: Baroreceptor and sympathetic activity in experimental renal hypertension. Circulation 17: 785, 1958.

    PubMed  CAS  Google Scholar 

  6. Krieger EM: Time course of baroreceptor resetting in acute hypertension. Am J Physiol 218: 486, 1970.

    PubMed  CAS  Google Scholar 

  7. Henry JP, Gauer OH, Reeves JL: Evidence of the atrial location of receptors influencing urine flow. Circ Res 4: 85, 1956.

    PubMed  CAS  Google Scholar 

  8. Mancia G, Lorenz RR, Shepherd JT: reflex control of circulation by heart and lungs. In: International Review of Physiology, Cardiovascular, Physiology - II, Vol. 9, p. 111. Guyton AC, Cowley AW, eds. Baltimore: University Park Press, 1976.

    Google Scholar 

  9. Thoren PN: Characteristic of left ventrivular receptors with non-medullated vagal afferents in cats. Circ Res 40: 415, 1977.

    PubMed  CAS  Google Scholar 

  10. Gauer OH, Henry JP: Neurohormonal control of plasma volume. In: Cardiovascular Physiology - II, Vol. 9, pp. 145–190. Guyton AC, Cowley AV, eds. Baltimore: University Park Press, 1976.

    Google Scholar 

  11. Epstein M, Pins DS, Arlington R, Denunzio AG, Engstrom R: Comparison of water immersion and saline infusion as a means of inducing volume expansion in man. J Appl Physiol 39: 66, 1975.

    PubMed  CAS  Google Scholar 

  12. Behne HJ, Gauer OH, Kirsch K, Eckert P: Effects of sustained intrathoracic vascular distention on body fluid distribution and renal excretion in man. Pfluegers Arch 313: 123, 1969.

    Article  Google Scholar 

  13. Gilmore JP, Zucker IM: Failure of left atrial distention to alter renal function in the non-human primate. Circ Res 42: 267, 1978.

    PubMed  CAS  Google Scholar 

  14. Mancia G, Romero JC, Shepherd JT: Continuous inhibition of renin release in dags by vagally innervated receptors in the cardiopulmonary region. Circ Res 36: 529, 1975.

    PubMed  CAS  Google Scholar 

  15. Mancia G, Romero JC, Strong CG: Neural influences on canine renal prostaglandin secretion. Acta Physiol Lat Am 24: 555, 1974.

    PubMed  CAS  Google Scholar 

  16. Thames MD: Reflex suppression of renin release by ventricular receptors with vagal afferents. Am J Physiol 233:HI81, 1978.

    Google Scholar 

  17. Kiowski W, Julius S: Renin response to stimulation of cardiopulmonary mechanoreceptors in man. J Clin Invest 62: 656, 1978.

    Article  PubMed  CAS  Google Scholar 

  18. Thames MD, Zubair-ul-Hassan, Brackett NC, Lower RR, Kontos HA: Plasma renin responses to hemorrhage after cardiac autotransplantation. Am J Physiol 221: 1115, 1971.

    PubMed  CAS  Google Scholar 

  19. Roddie C, Shepherd JT, Whelan RF: Reflex changes in vasoconstrictor tone in human skeletal muscle in response to stimulation of receptors in a low-pressure area of the intra-thoracic vascular bed. J Physiol 139: 369, 1957.

    PubMed  CAS  Google Scholar 

  20. Epstein M, Pins DS, Miller M: Suppression of ADH during water immersion in normal man. J Appl Physiol 38: 1038, 1975.

    PubMed  CAS  Google Scholar 

  21. Share L: The role of cardiovascular receptors in the control of ADH release. Cardiology 61 (Suppl 1): 51, 1976.

    Article  PubMed  Google Scholar 

  22. Gupta PD, Henry JP, Sinclair R, von Baumgarten R: Responses of atrial and aortic baroreceptors to nonhypotensive hemorrhage and to transfusion. Am J Physiol 211: 1429, 1966.

    PubMed  CAS  Google Scholar 

  23. Davis JO, Freeman RH: Mechanisms regulating renin release. Physiol Rev 56: 1, 1976.

    PubMed  CAS  Google Scholar 

  24. Guyton AC, Cowley AW Jr, Coleman TG, Liard JF, McCaa RE, Manning RD Jr, Norman RA Jr, Young DB: Pretubular versus tubular mechanisms of renal hypertension. In: Mechanisms of Hypertension, pp. 15–29. Sambhi MP, ed. Amsterdam: Excerpta Medica, 1973.

    Google Scholar 

  25. Peach MJ: Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57: 313, 1977.

    PubMed  CAS  Google Scholar 

  26. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232, 1971.

    CAS  Google Scholar 

  27. Romero JC, Dunlap CL, Strong CG: The effect of indomethacin and other anti-inflammatory drugs on the renin-angiotensin system. J Clin Invest 58: 282, 1976.

    Article  PubMed  CAS  Google Scholar 

  28. Weber PC, Larson C, Anggard E, Hamberg M, Corey EJ, Nicolau KC, Samuelsson B: Stimulation of renin release from rabbit renal cortex by arachidonic acid and prostaglandin endoperoxides. Circ Res 39: 868, 1976.

    CAS  Google Scholar 

  29. Weber PC, Larson C, Scherer B: Prostaglandin E2-9-keto-reductase as a mediator of salt intake-related prostaglandin-renin interaction. Nature 266: 65, 1977.

    Article  CAS  Google Scholar 

  30. Beierwaltes WH, Schryver S, Olson PS, Romero JC: Interaction of the prostaglandin and renin-angiotensin systems in isolated rat glomeruli. Am J Physiol (in press).

    Google Scholar 

  31. Romero JC, Strong CG: Hypertension and the interrelated renal circulatory effects of prostaglandins and the renin-angiotensin system. Mayo Clin Proc 52: 462, 1977.

    PubMed  CAS  Google Scholar 

  32. Romero JC, Beierwaltes WH: Renal prostaglandins in hypertension. Mineral Water Metab (in press).

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Martinus Nijhoff Publishers, The Hague

About this chapter

Cite this chapter

Romero, J.C., Beierwaltes, W.H., Houck, P.C. (1982). The Pathophysiology of Hypertension: Contributions of Experimental Pathophysiology. In: Amery, A., Fagard, R., Lijnen, P., Staessen, J. (eds) Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Developments in Cardiovascular Medicine, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7476-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-7476-0_9

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-7478-4

  • Online ISBN: 978-94-009-7476-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics